Amgen (NQ:AMGN)

403.04 -4.23 (-1.04%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

72 73 Next >

Martin Capital Buys Into Portland General Electric’s Defensive Power Play ↗

October 07, 2025

Via The Motley Fool

Topics Energy Regulatory Compliance

Amgen To Offer Cholesterol Drug At 60% Discount As Trump Administration's Call To Lower Drug Prices ↗

October 06, 2025

Amgen launches AmgenNow, offering Repatha at $239 per month, expanding direct access for U.S. patients with no insurer restrictions.

Via Benzinga

Topics Government

Martin Capital Dumps $3.0 Million Worth of LyondellBasell Industries Stock ↗

October 06, 2025

Via The Motley Fool

Topics Energy

Martin Capital Liquidates its Diageo Position: What That Means for the Alcoholic Beverages Titan ↗

October 06, 2025

Via The Motley Fool

P/E Ratio Insights for Amgen ↗

October 03, 2025

Via Benzinga

Martin Capital Exits $5.8 Million Comcast Stake as Broadband Challenges Persist ↗

October 06, 2025

Via The Motley Fool

Martin Capital Sells $3.6 Million in JPMorgan Stock — What to Know Ahead of Q3 Earnings ↗

October 06, 2025

Via The Motley Fool

Amgen To Sell Cholesterol Drug For Approximately 60% Discount ↗

October 06, 2025

Patients can purchase Repatha at a discount through Amgen’s direct-to-patient program, AmgenNow.

Via Stocktwits

Topics Government

4 Reasons to Buy Amgen Stock Right Now ↗

October 04, 2025

For those with a sufficiently long investment horizon, the stock looks attractive.

Via The Motley Fool

Topics Intellectual Property

Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets ↗

October 03, 2025

S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easing and AI tech.

Via Benzinga

Topics Artificial Intelligence Stocks

FDA Greenlights Jazz and Roche's Zepzelca-Tecentriq for ES-SCLC Maintenance, Reshaping Lung Cancer Treatment Landscape

October 03, 2025

In a pivotal moment for oncology, the U.S. Food and Drug Administration (FDA) on October 2, 2025, granted approval for the innovative combination of Jazz Pharmaceuticals' (NASDAQ: JAZZ) Zepzelca...

Via MarketMinute

U.S. Jobs Report Stalled Amidst Federal Shutdown: A Critical Information Vacuum for Markets and Policymakers

October 02, 2025

Washington D.C., October 2, 2025 – As a federal government shutdown extends into its second day, the highly anticipated U.S. Jobs Report, typically released on the first Friday of each month, has been...

Via MarketMinute

Topics Bonds Economy

Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience

October 02, 2025

On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Novo Nordisk (NVO) Soars as HSBC Upgrades to "Buy," Citing Strategic Focus and Pipeline Strength

October 02, 2025

Copenhagen, Denmark – October 2, 2025 – Shares of Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) experienced a significant surge yesterday, October 1, 2025, following a pivotal upgrade from HSBC....

Via MarketMinute

Topics Economy

These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap ↗

October 02, 2025

Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount.

Via Benzinga

Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings

October 02, 2025

Thousand Oaks, CA – October 2, 2025 – Amgen (NASDAQ: AMGN) has witnessed a robust surge in its share price, climbing approximately 6% in recent trading sessions, culminating on October 2, 2025, to...

Via MarketMinute

Topics Economy Intellectual Property Stocks

Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design

October 02, 2025

London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented...

Via TokenRing AI

Topics Artificial Intelligence

Stocks making big moves yesterday: ZoomInfo, Dave, Atkore, Saia, and Amgen

October 02, 2025

Check out the companies making headlines yesterday:

Via StockStory

Bruce Beutler Unlocked Key Mystery To Disease — And He's Not Done ↗

October 02, 2025

What's one piece of advice Dr. Bruce Beutler gives to anyone interested in excelling in science? Go outside. It worked for him.

Via Investor's Business Daily

2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer ↗

October 02, 2025

These stocks have been raising their payouts much faster than most dividend payers.

Via The Motley Fool

Topics Economy

Why Are Amgen (AMGN) Shares Soaring Today

October 01, 2025

Shares of biotech company Amgen (NASDAQ:AMGN) jumped 6.4% in the afternoon session after the company announced a $650 million investment to expand its US manufacturing network. The investment is aimed...

Via StockStory

Topics Economy Government Intellectual Property

Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday? ↗

October 01, 2025

Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat.

Via Benzinga

Which S&P500 stocks are moving on Wednesday? ↗

October 01, 2025

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff ↗

October 01, 2025

Drug stocks are celebrating in the wake of Trump's threat to levy a 100% tariff on pharmaceutical imports starting Wednesday.

Via Investor's Business Daily

Topics Economy Government World Trade

Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement

September 30, 2025

New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a...

Via MarketMinute

Topics Government

Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge

September 30, 2025

Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing...

Via MarketMinute

Topics Economy Government World Trade

Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.

Via StockStory

Topics Government

Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks ↗

September 30, 2025

Rep. Marjorie Taylor Greene's latest trades reveal a six-figure Treasury Bill buy, plus new stakes in tech stocks and a Bitcoin ETF.

Via Benzinga

Topics ETFs

Want Decades of Passive Income? Buy This Index Fund and Hold It Forever ↗

September 29, 2025

Dividend stocks can be a more predictable stream of income for investors.

Via The Motley Fool

Topics ETFs Stocks

Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Program ↗

September 29, 2025

The announcement from the group coincides with the deadline set by President Trump for 17 pharmaceutical companies to reduce drug prices in the U.S. to the levels paid by other developed countries.

Via Stocktwits

Topics Government

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.